nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—epilepsy syndrome	0.149	1	CbGaD
Atazanavir—ABCC1—Phenobarbital—epilepsy syndrome	0.0564	0.105	CbGbCtD
Atazanavir—ABCB1—Levetiracetam—epilepsy syndrome	0.0297	0.0553	CbGbCtD
Atazanavir—CYP2C9—Trimethadione—epilepsy syndrome	0.026	0.0485	CbGbCtD
Atazanavir—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0244	0.0456	CbGbCtD
Atazanavir—ABCB1—Clobazam—epilepsy syndrome	0.0206	0.0383	CbGbCtD
Atazanavir—ABCB1—Lamotrigine—epilepsy syndrome	0.0198	0.0369	CbGbCtD
Atazanavir—CYP2C9—Carbamazepine—epilepsy syndrome	0.0176	0.0327	CbGbCtD
Atazanavir—ABCB1—Carbamazepine—epilepsy syndrome	0.017	0.0318	CbGbCtD
Atazanavir—CYP2C9—Primidone—epilepsy syndrome	0.0164	0.0306	CbGbCtD
Atazanavir—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0163	0.0303	CbGbCtD
Atazanavir—CYP2C9—Phenytoin—epilepsy syndrome	0.0157	0.0294	CbGbCtD
Atazanavir—ABCB1—Phenytoin—epilepsy syndrome	0.0153	0.0285	CbGbCtD
Atazanavir—CYP3A4—Felbamate—epilepsy syndrome	0.0151	0.0282	CbGbCtD
Atazanavir—CYP3A4—Trimethadione—epilepsy syndrome	0.0151	0.0282	CbGbCtD
Atazanavir—CYP2C9—Propofol—epilepsy syndrome	0.0147	0.0274	CbGbCtD
Atazanavir—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0142	0.0265	CbGbCtD
Atazanavir—CYP2C9—Phenobarbital—epilepsy syndrome	0.014	0.0262	CbGbCtD
Atazanavir—ABCB1—Phenobarbital—epilepsy syndrome	0.0136	0.0254	CbGbCtD
Atazanavir—ABCB1—Midazolam—epilepsy syndrome	0.0134	0.025	CbGbCtD
Atazanavir—CYP2C9—Diazepam—epilepsy syndrome	0.0133	0.0248	CbGbCtD
Atazanavir—ABCB1—Diazepam—epilepsy syndrome	0.0129	0.0241	CbGbCtD
Atazanavir—CYP3A4—Clonazepam—epilepsy syndrome	0.0128	0.024	CbGbCtD
Atazanavir—CYP3A4—Clobazam—epilepsy syndrome	0.0123	0.023	CbGbCtD
Atazanavir—CYP2C9—Valproic Acid—epilepsy syndrome	0.0105	0.0196	CbGbCtD
Atazanavir—CYP3A4—Rufinamide—epilepsy syndrome	0.0105	0.0195	CbGbCtD
Atazanavir—CYP3A4—Carbamazepine—epilepsy syndrome	0.0102	0.019	CbGbCtD
Atazanavir—CYP3A4—Primidone—epilepsy syndrome	0.00953	0.0178	CbGbCtD
Atazanavir—CYP3A4—Phenytoin—epilepsy syndrome	0.00916	0.0171	CbGbCtD
Atazanavir—CYP3A4—Propofol—epilepsy syndrome	0.00854	0.0159	CbGbCtD
Atazanavir—CYP3A4—Acetazolamide—epilepsy syndrome	0.00816	0.0152	CbGbCtD
Atazanavir—CYP3A4—Phenobarbital—epilepsy syndrome	0.00816	0.0152	CbGbCtD
Atazanavir—CYP3A4—Midazolam—epilepsy syndrome	0.00805	0.015	CbGbCtD
Atazanavir—CYP3A4—Diazepam—epilepsy syndrome	0.00774	0.0144	CbGbCtD
Atazanavir—CYP3A4—Zonisamide—epilepsy syndrome	0.00755	0.0141	CbGbCtD
Atazanavir—CYP3A4—Valproic Acid—epilepsy syndrome	0.0061	0.0114	CbGbCtD
Atazanavir—CYP3A4—Topiramate—epilepsy syndrome	0.0055	0.0103	CbGbCtD
Atazanavir—Ritonavir—SLCO1A2—epilepsy syndrome	0.00086	0.157	CrCbGaD
Atazanavir—Saquinavir—SLCO1A2—epilepsy syndrome	0.000652	0.119	CrCbGaD
Atazanavir—Saquinavir—CYP11A1—epilepsy syndrome	0.000567	0.104	CrCbGaD
Atazanavir—Ritonavir—ABCC2—epilepsy syndrome	0.000411	0.0751	CrCbGaD
Atazanavir—Ritonavir—ABCG2—epilepsy syndrome	0.000364	0.0664	CrCbGaD
Atazanavir—Lopinavir—CYP2C19—epilepsy syndrome	0.00034	0.0621	CrCbGaD
Atazanavir—Saquinavir—ABCC2—epilepsy syndrome	0.000312	0.0569	CrCbGaD
Atazanavir—Ritonavir—CYP2C19—epilepsy syndrome	0.000286	0.0522	CrCbGaD
Atazanavir—Saquinavir—ABCG2—epilepsy syndrome	0.000276	0.0503	CrCbGaD
Atazanavir—Lopinavir—CYP2D6—epilepsy syndrome	0.000252	0.046	CrCbGaD
Atazanavir—Saquinavir—CYP2C19—epilepsy syndrome	0.000217	0.0396	CrCbGaD
Atazanavir—Ritonavir—CYP2D6—epilepsy syndrome	0.000212	0.0387	CrCbGaD
Atazanavir—Lopinavir—ABCB1—epilepsy syndrome	0.00018	0.0329	CrCbGaD
Atazanavir—Saquinavir—CYP2D6—epilepsy syndrome	0.000161	0.0293	CrCbGaD
Atazanavir—Ritonavir—ABCB1—epilepsy syndrome	0.000151	0.0276	CrCbGaD
Atazanavir—Saquinavir—ALB—epilepsy syndrome	0.00012	0.0219	CrCbGaD
Atazanavir—Saquinavir—ABCB1—epilepsy syndrome	0.000115	0.0209	CrCbGaD
Atazanavir—Cough—Pregabalin—epilepsy syndrome	4.88e-05	0.000193	CcSEcCtD
Atazanavir—Pruritus—Phenytoin—epilepsy syndrome	4.87e-05	0.000193	CcSEcCtD
Atazanavir—Connective tissue disorder—Topiramate—epilepsy syndrome	4.87e-05	0.000193	CcSEcCtD
Atazanavir—Nausea—Levetiracetam—epilepsy syndrome	4.87e-05	0.000193	CcSEcCtD
Atazanavir—Rash—Vigabatrin—epilepsy syndrome	4.86e-05	0.000192	CcSEcCtD
Atazanavir—Dizziness—Felbamate—epilepsy syndrome	4.86e-05	0.000192	CcSEcCtD
Atazanavir—Dermatitis—Vigabatrin—epilepsy syndrome	4.85e-05	0.000192	CcSEcCtD
Atazanavir—Urethral disorder—Topiramate—epilepsy syndrome	4.85e-05	0.000192	CcSEcCtD
Atazanavir—Pruritus—Oxcarbazepine—epilepsy syndrome	4.84e-05	0.000192	CcSEcCtD
Atazanavir—Convulsion—Pregabalin—epilepsy syndrome	4.84e-05	0.000192	CcSEcCtD
Atazanavir—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.84e-05	0.000191	CcSEcCtD
Atazanavir—Headache—Vigabatrin—epilepsy syndrome	4.83e-05	0.000191	CcSEcCtD
Atazanavir—Hypertension—Pregabalin—epilepsy syndrome	4.82e-05	0.000191	CcSEcCtD
Atazanavir—Vomiting—Diazepam—epilepsy syndrome	4.82e-05	0.000191	CcSEcCtD
Atazanavir—Anorexia—Valproic Acid—epilepsy syndrome	4.81e-05	0.00019	CcSEcCtD
Atazanavir—Rash—Diazepam—epilepsy syndrome	4.78e-05	0.000189	CcSEcCtD
Atazanavir—Dermatitis—Diazepam—epilepsy syndrome	4.78e-05	0.000189	CcSEcCtD
Atazanavir—Myalgia—Pregabalin—epilepsy syndrome	4.76e-05	0.000188	CcSEcCtD
Atazanavir—Chest pain—Pregabalin—epilepsy syndrome	4.76e-05	0.000188	CcSEcCtD
Atazanavir—Arthralgia—Pregabalin—epilepsy syndrome	4.76e-05	0.000188	CcSEcCtD
Atazanavir—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.75e-05	0.000188	CcSEcCtD
Atazanavir—Dizziness—Zonisamide—epilepsy syndrome	4.75e-05	0.000188	CcSEcCtD
Atazanavir—Headache—Diazepam—epilepsy syndrome	4.75e-05	0.000188	CcSEcCtD
Atazanavir—Anxiety—Pregabalin—epilepsy syndrome	4.74e-05	0.000188	CcSEcCtD
Atazanavir—Diarrhoea—Clonazepam—epilepsy syndrome	4.74e-05	0.000188	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.72e-05	0.000187	CcSEcCtD
Atazanavir—Asthenia—Carbamazepine—epilepsy syndrome	4.71e-05	0.000186	CcSEcCtD
Atazanavir—Agitation—Gabapentin—epilepsy syndrome	4.71e-05	0.000186	CcSEcCtD
Atazanavir—Diarrhoea—Phenytoin—epilepsy syndrome	4.71e-05	0.000186	CcSEcCtD
Atazanavir—Discomfort—Pregabalin—epilepsy syndrome	4.7e-05	0.000186	CcSEcCtD
Atazanavir—Nausea—Fosphenytoin—epilepsy syndrome	4.7e-05	0.000186	CcSEcCtD
Atazanavir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.68e-05	0.000185	CcSEcCtD
Atazanavir—Erythema multiforme—Topiramate—epilepsy syndrome	4.68e-05	0.000185	CcSEcCtD
Atazanavir—Angioedema—Gabapentin—epilepsy syndrome	4.68e-05	0.000185	CcSEcCtD
Atazanavir—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.68e-05	0.000185	CcSEcCtD
Atazanavir—Vomiting—Felbamate—epilepsy syndrome	4.67e-05	0.000185	CcSEcCtD
Atazanavir—Dry mouth—Pregabalin—epilepsy syndrome	4.65e-05	0.000184	CcSEcCtD
Atazanavir—Pruritus—Carbamazepine—epilepsy syndrome	4.65e-05	0.000184	CcSEcCtD
Atazanavir—Rash—Felbamate—epilepsy syndrome	4.63e-05	0.000183	CcSEcCtD
Atazanavir—Eye disorder—Topiramate—epilepsy syndrome	4.63e-05	0.000183	CcSEcCtD
Atazanavir—Dermatitis—Felbamate—epilepsy syndrome	4.63e-05	0.000183	CcSEcCtD
Atazanavir—Malaise—Gabapentin—epilepsy syndrome	4.62e-05	0.000183	CcSEcCtD
Atazanavir—Tinnitus—Topiramate—epilepsy syndrome	4.62e-05	0.000183	CcSEcCtD
Atazanavir—Headache—Felbamate—epilepsy syndrome	4.6e-05	0.000182	CcSEcCtD
Atazanavir—Confusional state—Pregabalin—epilepsy syndrome	4.6e-05	0.000182	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.6e-05	0.000182	CcSEcCtD
Atazanavir—Cardiac disorder—Topiramate—epilepsy syndrome	4.6e-05	0.000182	CcSEcCtD
Atazanavir—Syncope—Gabapentin—epilepsy syndrome	4.59e-05	0.000182	CcSEcCtD
Atazanavir—Dizziness—Clonazepam—epilepsy syndrome	4.58e-05	0.000181	CcSEcCtD
Atazanavir—Nausea—Vigabatrin—epilepsy syndrome	4.58e-05	0.000181	CcSEcCtD
Atazanavir—Vomiting—Zonisamide—epilepsy syndrome	4.57e-05	0.000181	CcSEcCtD
Atazanavir—Insomnia—Valproic Acid—epilepsy syndrome	4.56e-05	0.000181	CcSEcCtD
Atazanavir—Oedema—Pregabalin—epilepsy syndrome	4.56e-05	0.00018	CcSEcCtD
Atazanavir—Asthenia—Lamotrigine—epilepsy syndrome	4.55e-05	0.00018	CcSEcCtD
Atazanavir—Dizziness—Phenytoin—epilepsy syndrome	4.55e-05	0.00018	CcSEcCtD
Atazanavir—Rash—Zonisamide—epilepsy syndrome	4.53e-05	0.000179	CcSEcCtD
Atazanavir—Infection—Pregabalin—epilepsy syndrome	4.53e-05	0.000179	CcSEcCtD
Atazanavir—Palpitations—Gabapentin—epilepsy syndrome	4.53e-05	0.000179	CcSEcCtD
Atazanavir—Dermatitis—Zonisamide—epilepsy syndrome	4.53e-05	0.000179	CcSEcCtD
Atazanavir—Dizziness—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000179	CcSEcCtD
Atazanavir—Nausea—Diazepam—epilepsy syndrome	4.51e-05	0.000178	CcSEcCtD
Atazanavir—Loss of consciousness—Gabapentin—epilepsy syndrome	4.5e-05	0.000178	CcSEcCtD
Atazanavir—Headache—Zonisamide—epilepsy syndrome	4.5e-05	0.000178	CcSEcCtD
Atazanavir—Dyspnoea—Valproic Acid—epilepsy syndrome	4.5e-05	0.000178	CcSEcCtD
Atazanavir—Diarrhoea—Carbamazepine—epilepsy syndrome	4.49e-05	0.000178	CcSEcCtD
Atazanavir—Angiopathy—Topiramate—epilepsy syndrome	4.49e-05	0.000178	CcSEcCtD
Atazanavir—Pruritus—Lamotrigine—epilepsy syndrome	4.49e-05	0.000178	CcSEcCtD
Atazanavir—Shock—Pregabalin—epilepsy syndrome	4.49e-05	0.000178	CcSEcCtD
Atazanavir—Somnolence—Valproic Acid—epilepsy syndrome	4.48e-05	0.000177	CcSEcCtD
Atazanavir—Immune system disorder—Topiramate—epilepsy syndrome	4.47e-05	0.000177	CcSEcCtD
Atazanavir—Nervous system disorder—Pregabalin—epilepsy syndrome	4.47e-05	0.000177	CcSEcCtD
Atazanavir—Cough—Gabapentin—epilepsy syndrome	4.47e-05	0.000177	CcSEcCtD
Atazanavir—Mediastinal disorder—Topiramate—epilepsy syndrome	4.46e-05	0.000177	CcSEcCtD
Atazanavir—Dyspepsia—Valproic Acid—epilepsy syndrome	4.44e-05	0.000176	CcSEcCtD
Atazanavir—Convulsion—Gabapentin—epilepsy syndrome	4.44e-05	0.000176	CcSEcCtD
Atazanavir—Skin disorder—Pregabalin—epilepsy syndrome	4.43e-05	0.000175	CcSEcCtD
Atazanavir—Hypertension—Gabapentin—epilepsy syndrome	4.42e-05	0.000175	CcSEcCtD
Atazanavir—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.41e-05	0.000174	CcSEcCtD
Atazanavir—Vomiting—Clonazepam—epilepsy syndrome	4.4e-05	0.000174	CcSEcCtD
Atazanavir—Decreased appetite—Valproic Acid—epilepsy syndrome	4.38e-05	0.000174	CcSEcCtD
Atazanavir—Alopecia—Topiramate—epilepsy syndrome	4.38e-05	0.000173	CcSEcCtD
Atazanavir—Vomiting—Phenytoin—epilepsy syndrome	4.37e-05	0.000173	CcSEcCtD
Atazanavir—Rash—Clonazepam—epilepsy syndrome	4.37e-05	0.000173	CcSEcCtD
Atazanavir—Dermatitis—Clonazepam—epilepsy syndrome	4.36e-05	0.000173	CcSEcCtD
Atazanavir—Chest pain—Gabapentin—epilepsy syndrome	4.36e-05	0.000173	CcSEcCtD
Atazanavir—Arthralgia—Gabapentin—epilepsy syndrome	4.36e-05	0.000173	CcSEcCtD
Atazanavir—Myalgia—Gabapentin—epilepsy syndrome	4.36e-05	0.000173	CcSEcCtD
Atazanavir—Nausea—Felbamate—epilepsy syndrome	4.36e-05	0.000173	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.35e-05	0.000172	CcSEcCtD
Atazanavir—Vomiting—Oxcarbazepine—epilepsy syndrome	4.35e-05	0.000172	CcSEcCtD
Atazanavir—Fatigue—Valproic Acid—epilepsy syndrome	4.35e-05	0.000172	CcSEcCtD
Atazanavir—Anxiety—Gabapentin—epilepsy syndrome	4.35e-05	0.000172	CcSEcCtD
Atazanavir—Anorexia—Pregabalin—epilepsy syndrome	4.35e-05	0.000172	CcSEcCtD
Atazanavir—Dizziness—Carbamazepine—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Atazanavir—Diarrhoea—Lamotrigine—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Atazanavir—Headache—Clonazepam—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Atazanavir—Rash—Phenytoin—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Atazanavir—Mental disorder—Topiramate—epilepsy syndrome	4.34e-05	0.000172	CcSEcCtD
Atazanavir—Dermatitis—Phenytoin—epilepsy syndrome	4.33e-05	0.000172	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.33e-05	0.000171	CcSEcCtD
Atazanavir—Rash—Oxcarbazepine—epilepsy syndrome	4.32e-05	0.000171	CcSEcCtD
Atazanavir—Pain—Valproic Acid—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Atazanavir—Constipation—Valproic Acid—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Atazanavir—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Atazanavir—Headache—Phenytoin—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Atazanavir—Malnutrition—Topiramate—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Atazanavir—Discomfort—Gabapentin—epilepsy syndrome	4.31e-05	0.000171	CcSEcCtD
Atazanavir—Headache—Oxcarbazepine—epilepsy syndrome	4.29e-05	0.00017	CcSEcCtD
Atazanavir—Nausea—Zonisamide—epilepsy syndrome	4.27e-05	0.000169	CcSEcCtD
Atazanavir—Dry mouth—Gabapentin—epilepsy syndrome	4.27e-05	0.000169	CcSEcCtD
Atazanavir—Flatulence—Topiramate—epilepsy syndrome	4.25e-05	0.000168	CcSEcCtD
Atazanavir—Tension—Topiramate—epilepsy syndrome	4.23e-05	0.000167	CcSEcCtD
Atazanavir—Dysgeusia—Topiramate—epilepsy syndrome	4.22e-05	0.000167	CcSEcCtD
Atazanavir—Confusional state—Gabapentin—epilepsy syndrome	4.22e-05	0.000167	CcSEcCtD
Atazanavir—Dizziness—Lamotrigine—epilepsy syndrome	4.2e-05	0.000166	CcSEcCtD
Atazanavir—Nervousness—Topiramate—epilepsy syndrome	4.19e-05	0.000166	CcSEcCtD
Atazanavir—Oedema—Gabapentin—epilepsy syndrome	4.18e-05	0.000165	CcSEcCtD
Atazanavir—Vomiting—Carbamazepine—epilepsy syndrome	4.18e-05	0.000165	CcSEcCtD
Atazanavir—Back pain—Topiramate—epilepsy syndrome	4.17e-05	0.000165	CcSEcCtD
Atazanavir—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.16e-05	0.000164	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.15e-05	0.000164	CcSEcCtD
Atazanavir—Infection—Gabapentin—epilepsy syndrome	4.15e-05	0.000164	CcSEcCtD
Atazanavir—Rash—Carbamazepine—epilepsy syndrome	4.14e-05	0.000164	CcSEcCtD
Atazanavir—Dermatitis—Carbamazepine—epilepsy syndrome	4.14e-05	0.000164	CcSEcCtD
Atazanavir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.12e-05	0.000163	CcSEcCtD
Atazanavir—Insomnia—Pregabalin—epilepsy syndrome	4.12e-05	0.000163	CcSEcCtD
Atazanavir—Nausea—Clonazepam—epilepsy syndrome	4.11e-05	0.000163	CcSEcCtD
Atazanavir—Headache—Carbamazepine—epilepsy syndrome	4.11e-05	0.000163	CcSEcCtD
Atazanavir—Shock—Gabapentin—epilepsy syndrome	4.11e-05	0.000163	CcSEcCtD
Atazanavir—Nervous system disorder—Gabapentin—epilepsy syndrome	4.1e-05	0.000162	CcSEcCtD
Atazanavir—Nausea—Phenytoin—epilepsy syndrome	4.09e-05	0.000162	CcSEcCtD
Atazanavir—Dyspnoea—Pregabalin—epilepsy syndrome	4.07e-05	0.000161	CcSEcCtD
Atazanavir—Nausea—Oxcarbazepine—epilepsy syndrome	4.07e-05	0.000161	CcSEcCtD
Atazanavir—Skin disorder—Gabapentin—epilepsy syndrome	4.06e-05	0.000161	CcSEcCtD
Atazanavir—Somnolence—Pregabalin—epilepsy syndrome	4.05e-05	0.00016	CcSEcCtD
Atazanavir—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.04e-05	0.00016	CcSEcCtD
Atazanavir—Vomiting—Lamotrigine—epilepsy syndrome	4.04e-05	0.00016	CcSEcCtD
Atazanavir—Urticaria—Valproic Acid—epilepsy syndrome	4.01e-05	0.000159	CcSEcCtD
Atazanavir—Rash—Lamotrigine—epilepsy syndrome	4e-05	0.000158	CcSEcCtD
Atazanavir—Ill-defined disorder—Topiramate—epilepsy syndrome	4e-05	0.000158	CcSEcCtD
Atazanavir—Dermatitis—Lamotrigine—epilepsy syndrome	4e-05	0.000158	CcSEcCtD
Atazanavir—Abdominal pain—Valproic Acid—epilepsy syndrome	3.99e-05	0.000158	CcSEcCtD
Atazanavir—Body temperature increased—Valproic Acid—epilepsy syndrome	3.99e-05	0.000158	CcSEcCtD
Atazanavir—Anorexia—Gabapentin—epilepsy syndrome	3.99e-05	0.000158	CcSEcCtD
Atazanavir—Headache—Lamotrigine—epilepsy syndrome	3.98e-05	0.000157	CcSEcCtD
Atazanavir—Decreased appetite—Pregabalin—epilepsy syndrome	3.96e-05	0.000157	CcSEcCtD
Atazanavir—Agitation—Topiramate—epilepsy syndrome	3.96e-05	0.000157	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.94e-05	0.000156	CcSEcCtD
Atazanavir—Fatigue—Pregabalin—epilepsy syndrome	3.93e-05	0.000156	CcSEcCtD
Atazanavir—Nausea—Carbamazepine—epilepsy syndrome	3.9e-05	0.000154	CcSEcCtD
Atazanavir—Pain—Pregabalin—epilepsy syndrome	3.9e-05	0.000154	CcSEcCtD
Atazanavir—Constipation—Pregabalin—epilepsy syndrome	3.9e-05	0.000154	CcSEcCtD
Atazanavir—Malaise—Topiramate—epilepsy syndrome	3.89e-05	0.000154	CcSEcCtD
Atazanavir—Syncope—Topiramate—epilepsy syndrome	3.87e-05	0.000153	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.81e-05	0.000151	CcSEcCtD
Atazanavir—Palpitations—Topiramate—epilepsy syndrome	3.81e-05	0.000151	CcSEcCtD
Atazanavir—Loss of consciousness—Topiramate—epilepsy syndrome	3.79e-05	0.00015	CcSEcCtD
Atazanavir—Insomnia—Gabapentin—epilepsy syndrome	3.78e-05	0.00015	CcSEcCtD
Atazanavir—Nausea—Lamotrigine—epilepsy syndrome	3.77e-05	0.000149	CcSEcCtD
Atazanavir—Cough—Topiramate—epilepsy syndrome	3.76e-05	0.000149	CcSEcCtD
Atazanavir—Feeling abnormal—Pregabalin—epilepsy syndrome	3.76e-05	0.000149	CcSEcCtD
Atazanavir—Convulsion—Topiramate—epilepsy syndrome	3.73e-05	0.000148	CcSEcCtD
Atazanavir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.73e-05	0.000148	CcSEcCtD
Atazanavir—Dyspnoea—Gabapentin—epilepsy syndrome	3.73e-05	0.000148	CcSEcCtD
Atazanavir—Hypertension—Topiramate—epilepsy syndrome	3.72e-05	0.000147	CcSEcCtD
Atazanavir—Somnolence—Gabapentin—epilepsy syndrome	3.72e-05	0.000147	CcSEcCtD
Atazanavir—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.72e-05	0.000147	CcSEcCtD
Atazanavir—Dyspepsia—Gabapentin—epilepsy syndrome	3.68e-05	0.000146	CcSEcCtD
Atazanavir—Chest pain—Topiramate—epilepsy syndrome	3.67e-05	0.000145	CcSEcCtD
Atazanavir—Arthralgia—Topiramate—epilepsy syndrome	3.67e-05	0.000145	CcSEcCtD
Atazanavir—Myalgia—Topiramate—epilepsy syndrome	3.67e-05	0.000145	CcSEcCtD
Atazanavir—Anxiety—Topiramate—epilepsy syndrome	3.66e-05	0.000145	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.64e-05	0.000144	CcSEcCtD
Atazanavir—Decreased appetite—Gabapentin—epilepsy syndrome	3.63e-05	0.000144	CcSEcCtD
Atazanavir—Discomfort—Topiramate—epilepsy syndrome	3.63e-05	0.000143	CcSEcCtD
Atazanavir—Urticaria—Pregabalin—epilepsy syndrome	3.62e-05	0.000143	CcSEcCtD
Atazanavir—Asthenia—Valproic Acid—epilepsy syndrome	3.62e-05	0.000143	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.61e-05	0.000143	CcSEcCtD
Atazanavir—Fatigue—Gabapentin—epilepsy syndrome	3.61e-05	0.000143	CcSEcCtD
Atazanavir—Abdominal pain—Pregabalin—epilepsy syndrome	3.6e-05	0.000143	CcSEcCtD
Atazanavir—Body temperature increased—Pregabalin—epilepsy syndrome	3.6e-05	0.000143	CcSEcCtD
Atazanavir—Dry mouth—Topiramate—epilepsy syndrome	3.59e-05	0.000142	CcSEcCtD
Atazanavir—Pain—Gabapentin—epilepsy syndrome	3.58e-05	0.000141	CcSEcCtD
Atazanavir—Constipation—Gabapentin—epilepsy syndrome	3.58e-05	0.000141	CcSEcCtD
Atazanavir—Pruritus—Valproic Acid—epilepsy syndrome	3.57e-05	0.000141	CcSEcCtD
Atazanavir—Confusional state—Topiramate—epilepsy syndrome	3.55e-05	0.00014	CcSEcCtD
Atazanavir—Oedema—Topiramate—epilepsy syndrome	3.52e-05	0.000139	CcSEcCtD
Atazanavir—Infection—Topiramate—epilepsy syndrome	3.49e-05	0.000138	CcSEcCtD
Atazanavir—Shock—Topiramate—epilepsy syndrome	3.46e-05	0.000137	CcSEcCtD
Atazanavir—Diarrhoea—Valproic Acid—epilepsy syndrome	3.45e-05	0.000137	CcSEcCtD
Atazanavir—Nervous system disorder—Topiramate—epilepsy syndrome	3.45e-05	0.000137	CcSEcCtD
Atazanavir—Feeling abnormal—Gabapentin—epilepsy syndrome	3.45e-05	0.000136	CcSEcCtD
Atazanavir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.42e-05	0.000135	CcSEcCtD
Atazanavir—Skin disorder—Topiramate—epilepsy syndrome	3.42e-05	0.000135	CcSEcCtD
Atazanavir—Hyperhidrosis—Topiramate—epilepsy syndrome	3.4e-05	0.000135	CcSEcCtD
Atazanavir—Hypersensitivity—Pregabalin—epilepsy syndrome	3.36e-05	0.000133	CcSEcCtD
Atazanavir—Anorexia—Topiramate—epilepsy syndrome	3.35e-05	0.000133	CcSEcCtD
Atazanavir—Dizziness—Valproic Acid—epilepsy syndrome	3.34e-05	0.000132	CcSEcCtD
Atazanavir—Urticaria—Gabapentin—epilepsy syndrome	3.32e-05	0.000131	CcSEcCtD
Atazanavir—Abdominal pain—Gabapentin—epilepsy syndrome	3.31e-05	0.000131	CcSEcCtD
Atazanavir—Body temperature increased—Gabapentin—epilepsy syndrome	3.31e-05	0.000131	CcSEcCtD
Atazanavir—Asthenia—Pregabalin—epilepsy syndrome	3.27e-05	0.000129	CcSEcCtD
Atazanavir—Pruritus—Pregabalin—epilepsy syndrome	3.23e-05	0.000128	CcSEcCtD
Atazanavir—Vomiting—Valproic Acid—epilepsy syndrome	3.21e-05	0.000127	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.21e-05	0.000127	CcSEcCtD
Atazanavir—Insomnia—Topiramate—epilepsy syndrome	3.18e-05	0.000126	CcSEcCtD
Atazanavir—Rash—Valproic Acid—epilepsy syndrome	3.18e-05	0.000126	CcSEcCtD
Atazanavir—Dermatitis—Valproic Acid—epilepsy syndrome	3.18e-05	0.000126	CcSEcCtD
Atazanavir—Headache—Valproic Acid—epilepsy syndrome	3.16e-05	0.000125	CcSEcCtD
Atazanavir—Dyspnoea—Topiramate—epilepsy syndrome	3.14e-05	0.000124	CcSEcCtD
Atazanavir—Somnolence—Topiramate—epilepsy syndrome	3.13e-05	0.000124	CcSEcCtD
Atazanavir—Diarrhoea—Pregabalin—epilepsy syndrome	3.12e-05	0.000123	CcSEcCtD
Atazanavir—Dyspepsia—Topiramate—epilepsy syndrome	3.1e-05	0.000123	CcSEcCtD
Atazanavir—Hypersensitivity—Gabapentin—epilepsy syndrome	3.08e-05	0.000122	CcSEcCtD
Atazanavir—Decreased appetite—Topiramate—epilepsy syndrome	3.06e-05	0.000121	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.04e-05	0.00012	CcSEcCtD
Atazanavir—Fatigue—Topiramate—epilepsy syndrome	3.03e-05	0.00012	CcSEcCtD
Atazanavir—Dizziness—Pregabalin—epilepsy syndrome	3.02e-05	0.000119	CcSEcCtD
Atazanavir—Pain—Topiramate—epilepsy syndrome	3.01e-05	0.000119	CcSEcCtD
Atazanavir—Constipation—Topiramate—epilepsy syndrome	3.01e-05	0.000119	CcSEcCtD
Atazanavir—Asthenia—Gabapentin—epilepsy syndrome	3e-05	0.000119	CcSEcCtD
Atazanavir—Nausea—Valproic Acid—epilepsy syndrome	3e-05	0.000119	CcSEcCtD
Atazanavir—Pruritus—Gabapentin—epilepsy syndrome	2.96e-05	0.000117	CcSEcCtD
Atazanavir—Vomiting—Pregabalin—epilepsy syndrome	2.9e-05	0.000115	CcSEcCtD
Atazanavir—Feeling abnormal—Topiramate—epilepsy syndrome	2.9e-05	0.000115	CcSEcCtD
Atazanavir—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.88e-05	0.000114	CcSEcCtD
Atazanavir—Rash—Pregabalin—epilepsy syndrome	2.88e-05	0.000114	CcSEcCtD
Atazanavir—Dermatitis—Pregabalin—epilepsy syndrome	2.87e-05	0.000114	CcSEcCtD
Atazanavir—Diarrhoea—Gabapentin—epilepsy syndrome	2.86e-05	0.000113	CcSEcCtD
Atazanavir—Headache—Pregabalin—epilepsy syndrome	2.86e-05	0.000113	CcSEcCtD
Atazanavir—Urticaria—Topiramate—epilepsy syndrome	2.79e-05	0.000111	CcSEcCtD
Atazanavir—Body temperature increased—Topiramate—epilepsy syndrome	2.78e-05	0.00011	CcSEcCtD
Atazanavir—Abdominal pain—Topiramate—epilepsy syndrome	2.78e-05	0.00011	CcSEcCtD
Atazanavir—Dizziness—Gabapentin—epilepsy syndrome	2.77e-05	0.000109	CcSEcCtD
Atazanavir—Nausea—Pregabalin—epilepsy syndrome	2.71e-05	0.000107	CcSEcCtD
Atazanavir—Vomiting—Gabapentin—epilepsy syndrome	2.66e-05	0.000105	CcSEcCtD
Atazanavir—Rash—Gabapentin—epilepsy syndrome	2.64e-05	0.000104	CcSEcCtD
Atazanavir—Dermatitis—Gabapentin—epilepsy syndrome	2.63e-05	0.000104	CcSEcCtD
Atazanavir—Headache—Gabapentin—epilepsy syndrome	2.62e-05	0.000104	CcSEcCtD
Atazanavir—Hypersensitivity—Topiramate—epilepsy syndrome	2.59e-05	0.000103	CcSEcCtD
Atazanavir—Asthenia—Topiramate—epilepsy syndrome	2.52e-05	9.99e-05	CcSEcCtD
Atazanavir—Pruritus—Topiramate—epilepsy syndrome	2.49e-05	9.85e-05	CcSEcCtD
Atazanavir—Nausea—Gabapentin—epilepsy syndrome	2.48e-05	9.83e-05	CcSEcCtD
Atazanavir—Diarrhoea—Topiramate—epilepsy syndrome	2.41e-05	9.52e-05	CcSEcCtD
Atazanavir—Dizziness—Topiramate—epilepsy syndrome	2.33e-05	9.21e-05	CcSEcCtD
Atazanavir—Vomiting—Topiramate—epilepsy syndrome	2.24e-05	8.85e-05	CcSEcCtD
Atazanavir—Rash—Topiramate—epilepsy syndrome	2.22e-05	8.78e-05	CcSEcCtD
Atazanavir—Dermatitis—Topiramate—epilepsy syndrome	2.22e-05	8.77e-05	CcSEcCtD
Atazanavir—Headache—Topiramate—epilepsy syndrome	2.2e-05	8.72e-05	CcSEcCtD
Atazanavir—Nausea—Topiramate—epilepsy syndrome	2.09e-05	8.27e-05	CcSEcCtD
Atazanavir—CYP2C9—Metabolism—GAMT—epilepsy syndrome	2.07e-05	0.000367	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	2.07e-05	0.000367	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	2.07e-05	0.000367	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PNPO—epilepsy syndrome	2.07e-05	0.000367	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	2.06e-05	0.000366	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CA4—epilepsy syndrome	2.06e-05	0.000366	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—QDPR—epilepsy syndrome	2.06e-05	0.000366	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.05e-05	0.000366	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.03e-05	0.000361	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ADRA2A—epilepsy syndrome	2.02e-05	0.00036	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—BCHE—epilepsy syndrome	2.02e-05	0.000359	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.97e-05	0.00035	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.96e-05	0.00035	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—COX3—epilepsy syndrome	1.93e-05	0.000344	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.93e-05	0.000343	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SLC2A1—epilepsy syndrome	1.92e-05	0.000342	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.92e-05	0.000342	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.92e-05	0.000342	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.91e-05	0.000341	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.91e-05	0.00034	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PLCB1—epilepsy syndrome	1.9e-05	0.000338	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—TH—epilepsy syndrome	1.9e-05	0.000337	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.87e-05	0.000332	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.84e-05	0.000328	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.83e-05	0.000326	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.83e-05	0.000326	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.83e-05	0.000326	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.83e-05	0.000326	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.83e-05	0.000326	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.81e-05	0.000321	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.77e-05	0.000314	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.75e-05	0.000311	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCG2—epilepsy syndrome	1.72e-05	0.000306	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.71e-05	0.000304	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.71e-05	0.000304	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.71e-05	0.000304	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.71e-05	0.000304	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.71e-05	0.000304	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.7e-05	0.000303	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2C19—epilepsy syndrome	1.68e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.68e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.68e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.68e-05	0.000298	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.67e-05	0.000298	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.67e-05	0.000296	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP11A1—epilepsy syndrome	1.67e-05	0.000296	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.66e-05	0.000296	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.65e-05	0.000294	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SLC2A1—epilepsy syndrome	1.62e-05	0.000289	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.61e-05	0.000287	CbGpPWpGaD
Atazanavir—ABCC1—Disease—JUNB—epilepsy syndrome	1.61e-05	0.000287	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS1—epilepsy syndrome	1.6e-05	0.000285	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.58e-05	0.000281	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HMOX1—epilepsy syndrome	1.58e-05	0.000281	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.57e-05	0.000278	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.57e-05	0.000278	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.57e-05	0.000278	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CAT—epilepsy syndrome	1.56e-05	0.000278	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.56e-05	0.000277	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.56e-05	0.000277	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HBEGF—epilepsy syndrome	1.53e-05	0.000272	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ABCB1—epilepsy syndrome	1.52e-05	0.00027	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.51e-05	0.000268	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.51e-05	0.000268	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2D6—epilepsy syndrome	1.5e-05	0.000267	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.5e-05	0.000267	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT3—epilepsy syndrome	1.5e-05	0.000267	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.49e-05	0.000265	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.49e-05	0.000265	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.49e-05	0.000265	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.49e-05	0.000265	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.49e-05	0.000265	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.49e-05	0.000265	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.46e-05	0.000261	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ADAM10—epilepsy syndrome	1.46e-05	0.00026	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.46e-05	0.000259	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.46e-05	0.000259	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.45e-05	0.000258	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.43e-05	0.000255	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADRA2A—epilepsy syndrome	1.43e-05	0.000255	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—BCHE—epilepsy syndrome	1.43e-05	0.000254	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.42e-05	0.000253	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.42e-05	0.000253	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GPX1—epilepsy syndrome	1.41e-05	0.000251	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.4e-05	0.000248	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.39e-05	0.000247	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.39e-05	0.000247	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.38e-05	0.000246	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.37e-05	0.000243	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDC42—epilepsy syndrome	1.37e-05	0.000243	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.36e-05	0.000242	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.36e-05	0.000242	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.36e-05	0.000242	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.36e-05	0.000242	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC2A1—epilepsy syndrome	1.36e-05	0.000242	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.36e-05	0.000241	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PLCB1—epilepsy syndrome	1.34e-05	0.000239	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TH—epilepsy syndrome	1.34e-05	0.000238	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.33e-05	0.000237	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.32e-05	0.000236	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.32e-05	0.000236	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.32e-05	0.000235	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.3e-05	0.000231	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.3e-05	0.000231	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.3e-05	0.000231	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.27e-05	0.000226	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.27e-05	0.000225	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.27e-05	0.000225	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.26e-05	0.000225	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HES1—epilepsy syndrome	1.25e-05	0.000223	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.25e-05	0.000222	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AGT—epilepsy syndrome	1.24e-05	0.00022	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.24e-05	0.00022	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.24e-05	0.00022	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.22e-05	0.000217	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FYN—epilepsy syndrome	1.22e-05	0.000217	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.22e-05	0.000216	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—APOE—epilepsy syndrome	1.21e-05	0.000216	CbGpPWpGaD
Atazanavir—ABCC1—Disease—H2AFX—epilepsy syndrome	1.21e-05	0.000216	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.21e-05	0.000215	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.19e-05	0.000212	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.19e-05	0.000211	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.18e-05	0.000211	CbGpPWpGaD
Atazanavir—ABCC1—Disease—YWHAZ—epilepsy syndrome	1.17e-05	0.000208	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.16e-05	0.000207	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.14e-05	0.000203	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.14e-05	0.000203	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.14e-05	0.000202	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.13e-05	0.000201	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.13e-05	0.000201	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.13e-05	0.000201	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.13e-05	0.000201	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.13e-05	0.000201	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.13e-05	0.0002	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CCR5—epilepsy syndrome	1.13e-05	0.0002	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HMOX1—epilepsy syndrome	1.12e-05	0.000199	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.11e-05	0.000197	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CAT—epilepsy syndrome	1.1e-05	0.000196	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCB1—epilepsy syndrome	1.07e-05	0.000191	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.07e-05	0.00019	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TSC2—epilepsy syndrome	1.05e-05	0.000186	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—POMC—epilepsy syndrome	1.04e-05	0.000185	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.04e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.03e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.03e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.03e-05	0.000184	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOE—epilepsy syndrome	1.02e-05	0.000182	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.01e-05	0.000181	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1e-05	0.000179	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1e-05	0.000179	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GPX1—epilepsy syndrome	9.98e-06	0.000178	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.96e-06	0.000177	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.94e-06	0.000177	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6ST—epilepsy syndrome	9.62e-06	0.000171	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GBE1—epilepsy syndrome	9.6e-06	0.000171	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	9.6e-06	0.000171	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS2—epilepsy syndrome	9.54e-06	0.00017	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—epilepsy syndrome	9.5e-06	0.000169	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	9.38e-06	0.000167	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	9.38e-06	0.000167	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	9.02e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.78e-06	0.000156	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AGT—epilepsy syndrome	8.75e-06	0.000156	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.73e-06	0.000155	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOE—epilepsy syndrome	8.57e-06	0.000153	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	8.56e-06	0.000152	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.55e-06	0.000152	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.55e-06	0.000152	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	8.31e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.18e-06	0.000146	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	8.16e-06	0.000145	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	8.16e-06	0.000145	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.99e-06	0.000142	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	7.97e-06	0.000142	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	7.93e-06	0.000141	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.82e-06	0.000139	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF2—epilepsy syndrome	7.78e-06	0.000138	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.67e-06	0.000137	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	7.64e-06	0.000136	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	7.55e-06	0.000134	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.53e-06	0.000134	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	7.45e-06	0.000133	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	7.4e-06	0.000132	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—POMC—epilepsy syndrome	7.37e-06	0.000131	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.35e-06	0.000131	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.15e-06	0.000127	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTOR—epilepsy syndrome	7.08e-06	0.000126	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.04e-06	0.000125	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—epilepsy syndrome	7.02e-06	0.000125	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.84e-06	0.000122	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.82e-06	0.000121	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	6.81e-06	0.000121	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BCHE—epilepsy syndrome	6.78e-06	0.000121	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—epilepsy syndrome	6.72e-06	0.000119	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.7e-06	0.000119	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	6.68e-06	0.000119	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	6.47e-06	0.000115	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.4e-06	0.000114	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TH—epilepsy syndrome	6.38e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	6.36e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BCHE—epilepsy syndrome	6.33e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.18e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.18e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	6.04e-06	0.000108	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	5.98e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TH—epilepsy syndrome	5.96e-06	0.000106	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—epilepsy syndrome	5.88e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.86e-06	0.000104	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SRC—epilepsy syndrome	5.67e-06	0.000101	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.32e-06	9.47e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAT—epilepsy syndrome	5.25e-06	9.34e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.04e-06	8.97e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	4.97e-06	8.84e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.91e-06	8.74e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAT—epilepsy syndrome	4.9e-06	8.73e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.88e-06	8.69e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.77e-06	8.49e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.75e-06	8.45e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX1—epilepsy syndrome	4.44e-06	7.89e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.41e-06	7.84e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.2e-06	7.46e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.18e-06	7.43e-05	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	4.18e-06	7.43e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AGT—epilepsy syndrome	4.16e-06	7.41e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOE—epilepsy syndrome	4.08e-06	7.26e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.99e-06	7.09e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.94e-06	7.01e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TH—epilepsy syndrome	3.93e-06	6.99e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.89e-06	6.92e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.81e-06	6.78e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—epilepsy syndrome	3.53e-06	6.27e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—POMC—epilepsy syndrome	3.5e-06	6.23e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.28e-06	5.83e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—POMC—epilepsy syndrome	3.27e-06	5.82e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.23e-06	5.75e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—epilepsy syndrome	3.19e-06	5.68e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.15e-06	5.6e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.98e-06	5.31e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—epilepsy syndrome	2.95e-06	5.25e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.93e-06	5.2e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.8e-06	4.97e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.61e-06	4.65e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.56e-06	4.56e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.51e-06	4.47e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.16e-06	3.84e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.97e-06	3.5e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.72e-06	3.06e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.4e-06	2.5e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.31e-06	2.33e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—epilepsy syndrome	8.65e-07	1.54e-05	CbGpPWpGaD
